Rate My Professor Caroline Trotter

Professor Caroline Trotter is Professor of Global Health in the Faculty of Medicine at Imperial College London, within the School of Public Health, Department of Infectious Disease Epidemiology, and part of the MRC Centre for Global Infectious Disease Analysis. She serves as Director of the Vaccine Impact Modelling Consortium, hosted at Imperial College London. Additionally, she holds the position of Professor of Global Health and Director for Cambridge-Africa at the University of Cambridge, Department of Veterinary Medicine. Her academic background includes a first degree in Human Sciences from the University of Oxford, an MSc in Infectious Disease Epidemiology, and a PhD in Epidemiology from the London School of Hygiene and Tropical Medicine, University of London. Prior to her current roles, she worked at the Health Protection Agency and the University of Bristol before joining Cambridge in January 2013.

An infectious disease epidemiologist, Professor Trotter's research focuses on vaccine-preventable diseases, particularly bacterial meningitis and meningococcal infection, with studies conducted in Europe and Africa. Her work encompasses group B streptococcus, pneumococcus, rotavirus, norovirus, HPV, and rabies, employing methods such as analysis of large databases, systematic reviews, prospective clinical and field studies, health economics, seroprevalence studies, and mathematical modelling to inform vaccine policy. Key publications include 'Global epidemiology of meningococcal disease' (Harrison et al., Vaccine, 2009), 'Meningococcal carriage by age: a systematic review and meta-analysis' (Christensen et al., The Lancet Infectious Diseases, 2010), 'Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction' (Trotter et al., The Lancet, 2004), 'Efficacy of pneumococcal vaccination in adults: a meta-analysis' (Huss et al., CMAJ, 2009), and 'Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study' (Li et al., The Lancet, 2021). She is a member of the WHO Technical Taskforce for Defeating Meningitis by 2030, chair of the Meningitis Research Foundation Scientific Advisory Panel, and a member of the Joint Committee on Vaccination and Immunisation. Her contributions influence global vaccine policy through collaborations with the World Health Organization and UK Health Security Agency.